These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15379671)

  • 1. The NF-kappaB pathway as a potential target for autoimmune disease therapy.
    Bacher S; Schmitz ML
    Curr Pharm Des; 2004; 10(23):2827-37. PubMed ID: 15379671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of nuclear factor-kappaB in the development of autoimmune diseases: a link between genes and environment.
    Kuryłowicz A; Nauman J
    Acta Biochim Pol; 2008; 55(4):629-47. PubMed ID: 19081854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the NF-kappaB pathway in the pathogenesis of human disease states.
    Yamamoto Y; Gaynor RB
    Curr Mol Med; 2001 Jul; 1(3):287-96. PubMed ID: 11899077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of NF-κB Signaling as a Therapeutic Target in Autoimmunity.
    Herrington FD; Carmody RJ; Goodyear CS
    J Biomol Screen; 2016 Mar; 21(3):223-42. PubMed ID: 26597958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune deficiency or hyperactivity-Nf-kappab illuminates autoimmunity.
    Pai S; Thomas R
    J Autoimmun; 2008 Nov; 31(3):245-51. PubMed ID: 18539434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear Factor-kappaB in Autoimmunity: Man and Mouse.
    Miraghazadeh B; Cook MC
    Front Immunol; 2018; 9():613. PubMed ID: 29686669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappa B as a therapeutic target in autoimmune disease.
    O'Sullivan B; Thompson A; Thomas R
    Expert Opin Ther Targets; 2007 Feb; 11(2):111-22. PubMed ID: 17227228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [NF-kappaB as a therapeutic target of rheumatoid arthritis].
    Okamoto T; Tsuchiya A
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Oct; 30(5):383-9. PubMed ID: 17984578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of rheumatoid arthritis with NF-kappaB inhibitors].
    Jimi E; Nakamura I
    Nihon Rinsho; 2005 Sep; 63(9):1627-32. PubMed ID: 16164222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear transcription factor NF-kappa B: role in biology and medicine.
    Aggarwal BB; Takada Y; Shishodia S; Gutierrez AM; Oommen OV; Ichikawa H; Baba Y; Kumar A
    Indian J Exp Biol; 2004 Apr; 42(4):341-53. PubMed ID: 15088683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer.
    Calzado MA; Bacher S; Schmitz ML
    Curr Med Chem; 2007; 14(3):367-76. PubMed ID: 17305539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of nuclear factor-κB in autoimmunity.
    Sun SC; Chang JH; Jin J
    Trends Immunol; 2013 Jun; 34(6):282-9. PubMed ID: 23434408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule inhibitors of NF-kappaB for the treatment of inflammatory joint disease.
    Roshak AK; Callahan JF; Blake SM
    Curr Opin Pharmacol; 2002 Jun; 2(3):316-21. PubMed ID: 12020477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling via NF-kappaB in the nervous system.
    Kaltschmidt B; Widera D; Kaltschmidt C
    Biochim Biophys Acta; 2005 Sep; 1745(3):287-99. PubMed ID: 15993497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of NF-kappaB signaling pathways by proteomic approaches.
    Niederberger E; Geisslinger G
    Expert Rev Proteomics; 2010 Apr; 7(2):189-203. PubMed ID: 20377387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nuclear factor-kappaB in the immune system and bone.
    Jimi E; Ghosh S
    Immunol Rev; 2005 Dec; 208():80-7. PubMed ID: 16313342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of NF-kappa B in virus-infected macrophages is dependent on mitochondrial oxidative stress and intracellular calcium: downstream involvement of the kinases TGF-beta-activated kinase 1, mitogen-activated kinase/extracellular signal-regulated kinase kinase 1, and I kappa B kinase.
    Mogensen TH; Melchjorsen J; Höllsberg P; Paludan SR
    J Immunol; 2003 Jun; 170(12):6224-33. PubMed ID: 12794154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of NF-κB signaling as a strategy in disease therapy.
    Gilmore TD; Garbati MR
    Curr Top Microbiol Immunol; 2011; 349():245-63. PubMed ID: 21113699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation, NF-κB, and Chronic Diseases: How are They Linked?
    Kunnumakkara AB; Shabnam B; Girisa S; Harsha C; Banik K; Devi TB; Choudhury R; Sahu H; Parama D; Sailo BL; Thakur KK; Gupta SC; Aggarwal BB
    Crit Rev Immunol; 2020; 40(1):1-39. PubMed ID: 32421977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MaxiK blockade selectively inhibits the lipopolysaccharide-induced I kappa B-alpha /NF-kappa B signaling pathway in macrophages.
    Papavlassopoulos M; Stamme C; Thon L; Adam D; Hillemann D; Seydel U; Schromm AB
    J Immunol; 2006 Sep; 177(6):4086-93. PubMed ID: 16951373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.